Neither immune defect disease nor underlying solid malignancy was associated with death, but the patients who died showed a higher proportion of haematological diseases and lower CD4+, CD8+, and B lymphocyte cell counts than the patients who survived. This evidence concerns the gene CD8A and cancer.